Schizophrenia susceptibility pathway neuregulin 1-ErbB4 suppresses Src upregulation of NMDA receptors

Nature Medicine

Volumn 17, Issue 4, 2011, Pages 470-478

  Pitcher, Graham M ^a,b   Kalia, Lorraine V ^a,b   Ng, David ^a   Goodfellow, Nathalie M ^b   Yee, Kathleen T ^c   Lambe, Evelyn K ^b   Salter, Michael W ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 4; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEU DIFFERENTIATION FACTOR; TYROSINE;

ANIMAL TISSUE; ARTICLE; DISEASE PREDISPOSITION; ENZYME ACTIVITY; EXCITATORY POSTSYNAPTIC POTENTIAL; HIPPOCAMPUS; LONG TERM POTENTIATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SRC HOMOLOGY DOMAIN; UPREGULATION;

ANIMALS; CA1 REGION, HIPPOCAMPAL; DISEASE SUSCEPTIBILITY; ELECTRIC STIMULATION; EXCITATORY POSTSYNAPTIC POTENTIALS; HUMANS; MALE; MICE; MICE, INBRED C57BL; MODELS, NEUROLOGICAL; NEUREGULIN-1; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, N-METHYL-D-ASPARTATE; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES;

EID: 79953751193     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.2315     Document Type: Article

References (60)

1. Dingledine, R., Borges, K., Bowie, D. & Traynelis, S.F. The glutamate receptor ion channels. Pharmacol. Rev. 51, 7-61 (1999) (Pubitemid 29113865)
2. Paoletti, P. & Neyton, J. NMDA receptor subunits: function and pharmacology. Curr. Opin. Pharmacol. 7, 39-47 (2007) (Pubitemid 46238036)
3. Grant, S.G. & Blackstock, W.P. Proteomics in neuroscience: from protein to network. J. Neurosci. 21, 8315-8318 (2001) (Pubitemid 33051427)
4. Liu, X.J. et al. Treatment of inflammatory and neuropathic pain by uncoupling Src from the NMDA receptor complex. Nat. Med. 14, 1325-1332 (2008)
5. Lu, Y.M., Roder, J.C., Davidow, J. & Salter, M.W. Src activation in the induction of long-term potentiation in CA1 hippocampal neurons. Science 279, 1363-1367 (1998) (Pubitemid 28119580)
6. MacDonald, J.F., Kotecha, S.A., Lu, W.Y. & Jackson, M.F. Convergence of PKC-dependent kinase signal cascades on NMDA receptors. Curr. Drug Targets 2, 299-312 (2001) (Pubitemid 32821472)
7. Salter, M.W. & Kalia, L.V. Src kinases: a hub for NMDA receptor regulation. Nat. Rev. Neurosci. 5, 317-328 (2004) (Pubitemid 38478658)
8. Coyle, J.T., Tsai, G. & Goff, D. Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia. Ann. NY Acad. Sci. 1003, 318-327 (2003) (Pubitemid 38083065)
9. Pilowsky, L.S. et al. First in vivo evidence of an NMDA receptor deficit in medication-free schizophrenic patients. Mol. Psychiatry 11, 118-119 (2006) (Pubitemid 43164609)
10. Balu, D.T. & Coyle, J.T. Neuroplasticity signaling pathways linked to the pathophysiology of schizophrenia. Neurosci. Biobehav. Rev. 35, 848-870 (2011)
11. Lindsley, C.W. et al. Progress towards validating the NMDA receptor hypofunction hypothesis of schizophrenia. Curr. Top. Med. Chem. 6, 771-785 (2006)
12. Hahn, C.G. et al. Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia. Nat. Med. 12, 824-828 (2006)
13. Yu, X.M., Askalan, R., Keil, G.J. & Salter, M.W. NMDA channel regulation by channel-associated protein tyrosine kinase Src. Science 275, 674-678 (1997) (Pubitemid 27061336)
14. Stefansson, H. et al. Neuregulin 1 and susceptibility to schizophrenia. Am. J. Hum. Genet. 71, 877-892 (2002) (Pubitemid 135750519)
15. Yang, J.Z. et al. Association study of neuregulin 1 gene with schizophrenia. Mol. Psychiatry 8, 706-709 (2003) (Pubitemid 36976302)
16. Hashimoto, R. et al. Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia. Mol. Psychiatry 9, 299-307 (2004) (Pubitemid 38496722)
17. Harrison, P.J. & Law, A.J. Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology. Biol. Psychiatry 60, 132-140 (2006)
18. Nicodemus, K.K. et al. Further evidence for association between ErbB4 and schizophrenia and influence on cognitive intermediate phenotypes in healthy controls. Mol. Psychiatry 11, 1062-1065 (2006) (Pubitemid 44863428)
19. Norton, N. et al. Evidence that interaction between neuregulin 1 and its receptor erbB4 increases susceptibility to schizophrenia. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 141B, 96-101 (2006) (Pubitemid 43062550)
20. Silberberg, G., Darvasi, A., Pinkas-Kramarski, R. & Navon, R. The involvement of ErbB4 with schizophrenia: association and expression studies. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 141B, 142-148 (2006) (Pubitemid 43214789)
21. Law, A.J., Kleinman, J.E., Weinberger, D.R. & Weickert, C.S. Disease-associated intronic variants in the ErbB4 gene are related to altered ErbB4 splice-variant expression in the brain in schizophrenia. Hum. Mol. Genet. 16, 129-141 (2007) (Pubitemid 46178996)
22. Tan, W. et al. Molecular cloning of a brain-specific, developmentally regulated neuregulin 1 (NRG1) isoform and identification of a functional promoter variant associated with schizophrenia. J. Biol. Chem. 282, 24343-24351 (2007) (Pubitemid 47328000)
23. Colantuoni, C. et al. Age-related changes in the expression of schizophrenia susceptibility genes in the human prefrontal cortex. Brain Struct. Funct. 213, 255-271 (2008)
24. Nicodemus, K.K. et al. A 5′ promoter region SNP in NRG1 is associated with schizophrenia risk and type III isoform expression. Mol. Psychiatry 14, 741-743 (2009)
25. Chen, Y.J. et al. Type III neuregulin-1 is required for normal sensorimotor gating, memory-related behaviors, and corticostriatal circuit components. J. Neurosci. 28, 6872-6883 (2008)
26. O'Tuathaigh, C.M. et al. Disruption to social dyadic interactions but not emotional/anxiety-related behaviour in mice with heterozygous 'knockout' of the schizophrenia risk gene neuregulin-1. Prog. Neuropsychopharmacol. Biol. Psychiatry 32, 462-466 (2008) (Pubitemid 351178964)
27. Duffy, L., Cappas, E., Lai, D., Boucher, A.A. & Karl, T. Cognition in transmembrane domain neuregulin 1 mutant mice. Neuroscience 170, 800-807 (2010)
28. Deakin, I.H. et al. Behavioural characterization of neuregulin 1 type I overexpressing transgenic mice. Neuroreport 20, 1523-1528 (2009)
29. Kato, T. et al. Phenotypic characterization of transgenic mice overexpressing neuregulin-1. PLoS ONE 5, e14185 (2010)
30. Chong, V.Z. et al. Elevated neuregulin-1 and ErbB4 protein in the prefrontal cortex of schizophrenic patients. Schizophr. Res. 100, 270-280 (2008)
31. Law, A.J. et al. Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5′ SNPs associated with the disease. Proc. Natl. Acad. Sci. USA 103, 6747-6752 (2006)
32. Huang, Y.Z. et al. Regulation of neuregulin signaling by PSD-95 interacting with ErbB4 at CNS synapses. Neuron 26, 443-455 (2000)
33. Ma, L. et al. Ligand-dependent recruitment of the ErbB4 signaling complex into neuronal lipid rafts. J. Neurosci. 23, 3164-3175 (2003). (Pubitemid 36531958)
34. Bjarnadottir, M. et al. Neuregulin1 (NRG1) signaling through Fyn modulates NMDA receptor phosphorylation: differential synaptic function in Nrg1+/? knock-outs compared with wild-type mice. J. Neurosci. 27, 4519-4529 (2007) (Pubitemid 46663586)
35. Kwon, O.B., Longart, M., Vullhorst, D., Hoffman, D.A. & Buonanno, A. Neuregulin-1 reverses long-term potentiation at CA1 hippocampal synapses. J. Neurosci. 25, 9378-9383 (2005) (Pubitemid 41464750)
36. Pitcher, G.M., Beggs, S., Woo, R.S., Mei, L. & Salter, M.W. ErbB4 is a suppressor of long-term potentiation in the adult hippocampus. Neuroreport 19, 139-143 (2008)
37. Iyengar, S.S. & Mott, D.D. Neuregulin blocks synaptic strengthening after epileptiform activity in the rat hippocampus. Brain Res. 1208, 67-73 (2008)
38. Huang, Y. et al. CAK?/Pyk2 kinase is a signaling link for induction of long-term potentiation in CA1 hippocampus. Neuron 29, 485-496 (2001) (Pubitemid 32206485)
39. Pelkey, K.A. et al. Tyrosine phosphatase STEP is a tonic brake on induction of long-term potentiation. Neuron 34, 127-138 (2002) (Pubitemid 34270704)
40. Gao, X.M. et al. Ionotropic glutamate receptors and expression of N-methyl-d-aspartate receptor subunits in subregions of human hippocampus: effects of schizophrenia. Am. J. Psychiatry 157, 1141-1149 (2000)
41. Siekmeier, P.J., Hasselmo, M.E., Howard, M.W. & Coyle, J. Modeling of context-dependent retrieval in hippocampal region CA1: implications for cognitive function in schizophrenia. Schizophr. Res. 89, 177-190 (2007) (Pubitemid 44881289)
42. Zierhut, K. et al. The role of hippocampus dysfunction in deficient memory encoding and positive symptoms in schizophrenia. Psychiatry Res. 183, 187-194 (2010)
43. Benetti, S. et al. Functional integration between the posterior hippocampus and prefrontal cortex is impaired in both first episode schizophrenia and the at risk mental state. Brain 132, 2426-2436 (2009)
44. Tidcombe, H. et al. Neural and mammary gland defects in ErbB4 knockout mice genetically rescued from embryonic lethality. Proc. Natl. Acad. Sci. USA 100, 8281-8286 (2003) (Pubitemid 36842536)
45. Fukazawa, R. et al. Neuregulin-1 protects ventricular myocytes from anthracycline-induced apoptosis via erbB4-dependent activation of PI3-kinase/Akt. J. Mol. Cell. Cardiol. 35, 1473-1479 (2003) (Pubitemid 37491190)
46. Woo, R.S. et al. Neuregulin-1 enhances depolarization-induced GABA release. Neuron 54, 599-610 (2007)
47. Macdonald, D.S. et al. Modulation of NMDA receptors by pituitary adenylate cyclase activating peptide in CA1 neurons requires G q, protein kinase C and activation of Src. J. Neurosci. 25, 11374-11384 (2005)
48. Xu, J. et al. Control of excitatory synaptic transmission by C-terminal Src kinase. J. Biol. Chem. 283, 17503-17514 (2008)
49. Gu, Z., Jiang, Q., Fu, A.K., Ip, N.Y. & Yan, Z. Regulation of NMDA receptors by neuregulin signaling in prefrontal cortex. J. Neurosci. 25, 4974-4984 (2005) (Pubitemid 40712840)
50. Eisenberg, D.P. & Berman, K.F. Executive function, neural circuitry and genetic mechanisms in schizophrenia. Neuropsychopharmacology 35, 258-277 (2010)
51. Merrill, M.A., Chen, Y., Strack, S. & Hell, J.W. Activity-driven postsynaptic translocation of CaMKII. Trends Pharmacol. Sci. 26, 645-653 (2005) (Pubitemid 41636310)
52. Rostas, J.A. et al. Enhanced tyrosine phosphorylation of the 2B subunit of the N-methyl-Dd-aspartate receptor in long-term potentiation. Proc. Natl. Acad. Sci. USA 93, 10452-10456 (1996)
53. Rosenblum, K., Dudai, Y. & Richter-Levin, G. Long-term potentiation increases tyrosine phosphorylation of the N-methyl-aspartate receptor subunit 2B in rat dentate gyrus in vivo. Proc. Natl. Acad. Sci. USA 93, 10457-10460 (1996)
54. Kim, H. et al. The c-Src tyrosine kinase associates with the catalytic domain of ErbB-2: implications for ErbB-2 mediated signaling and transformation. Oncogene 24, 7599-7607 (2005) (Pubitemid 41638034)
55. Olayioye, M.A., Beuvink, I., Horsch, K., Daly, J.M. & Hynes, N.E. ErbB receptor-induced activation of stat transcription factors is mediated by Src tyrosine kinases. J. Biol. Chem. 274, 17209-17218 (1999)
56. Lisman, J. & Buzsaki, G. A neural coding scheme formed by the combined function of gamma and theta oscillations. Schizophr. Bull. 34, 974-980 (2008)
57. Uhlhaas, P.J., Haenschel, C., Nikolic, D. & Singer, W. The role of oscillations and synchrony in cortical networks and their putative relevance for the pathophysiology of schizophrenia. Schizophr. Bull. 34, 927-943 (2008)
58. Lei, G. et al. Gain control of N-methyl-d-aspartate receptor activity by receptor-like protein tyrosine phosphatase alpha. EMBO J. 21, 2977-2989 (2002) (Pubitemid 34670382)
59. Kalia, L.V., Pitcher, G.M., Pelkey, K.A. & Salter, M.W. PSD-95 is a negative regulator of the tyrosine kinase Src in the NMDA receptor complex. EMBO J. 25, 4971-4982 (2006) (Pubitemid 44607041)
60. Eilam, R., Pinkas-Kramarski, R., Ratzkin, B.J., Segal, M. & Yarden, Y. Activity-dependent regulation of Neu differentiation factor/neuregulin expression in rat brain. Proc. Natl. Acad. Sci. USA 95, 1888-1893 (1998). (Pubitemid 28103489)